首页> 外国专利> Use of anti-CXCL16 and anti-CXCR6 antibodies to treat or detect cancer

Use of anti-CXCL16 and anti-CXCR6 antibodies to treat or detect cancer

机译:抗CXCL16和抗CXCR6抗体在治疗或检测癌症中的用途

摘要

Methods for prevention or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a therapeutically effective amount of an antibody to the chemokine CXCL16 and/or the chemokine receptor CXCR6. Another method comprises the step of administering to the subject a therapeutically effective amount of an expression vector that expresses an antibody to the chemokine CXCL16 and/or the chemokine receptor CXCR6.
机译:公开了用于预防或抑制受试者中癌细胞的生长或转移的方法。一种方法包括对受试者施用治疗有效量的趋化因子CXCL16和/或趋化因子受体CXCR6的抗体的步骤。另一方法包括向受试者施用治疗有效量的表达载体的步骤,所述表达载体表达针对趋化因子CXCL16和/或趋化因子受体CXCR6的抗体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号